Related by context. All words. (Click for frequent words.) 63 papillary renal cell carcinoma 62 bone grafting procedures 62 GEM OS2 61 recurrent metastatic 61 prostate carcinomas 60 cartilage lesions 60 bony metastases 60 Genasense ® 60 sacroiliac joints 60 oral deforolimus 60 cervical lymph nodes 60 pain palliation 60 calcaneal fractures 60 structure infections ABSSSI 60 femoral neck fractures 60 regenerating bone 60 pulmonary metastases 59 metastatic bladder 59 telomerase inhibition 59 Mohs micrographic surgery 59 CYT# potent vascular disrupting 59 SUCCEED trial 59 keloid scars 59 ulnar styloid 59 heavily pretreated 59 skeletal metastases 59 Vicinium TM 59 Augment Injectable 59 basal cell carcinoma BCC 58 lipomas 58 Combidex 58 fusion enhancers 58 fibroma 58 distal femur 58 renal tumors 58 recurrent glioblastoma multiforme 58 lymphomas leukemias 58 evaluating Prochymal 58 metastatic lesions 58 acute peripheral arterial 58 refractory ovarian cancer 58 preoperative diagnosis 58 histopathologic examination 58 osteoporotic compression fractures 58 pancreatic islet cell 57 WallFlex Biliary RX 57 humanised monoclonal antibody 57 vertebral compression fracture 57 myomas 57 Bone Graft 57 posttraumatic arthritis 57 Allovectin 7 ® 57 Proxinium TM 57 chondral 57 EGFR mutation positive 57 vertebral compression fractures 57 recurrent NSCLC 57 squamous cell carcinoma SCC 57 cartilage regeneration 57 hepatocellular cancer 57 spinal pathologies 57 metastatic pancreatic 57 arthrography 57 Xanafide 57 radiographic findings 57 metastatic GIST 57 sarcoma melanoma 57 acyclovir Lauriad R 57 Surgical resection 57 demonstrated antitumor activity 57 Surgical excision 57 urothelial cancer 57 malignant prostate 57 Humeral 57 nonunions 57 lung pancreatic 57 Bankart lesion 56 Calcium phosphate 56 longus tendon 56 lenalidomide Revlimid R 56 concurrent chemoradiation 56 renal cell carcinomas 56 autografts 56 pseudoaneurysms 56 pancreatic adenocarcinoma 56 basal cell cancers 56 Aflibercept 56 osteoid 56 fracture fixation 56 relapsing remitting MS RRMS 56 postoperative chemotherapy 56 scleral buckling 56 medically inoperable 56 tumoral 56 catheter occlusion 56 Pivotal Clinical Trial 56 metastatic gastric 56 thymectomy 56 phase IIb study 56 excisional 56 extracranial 56 Aplidin 56 cytokine refractory 56 squamous carcinoma 56 EOquin TM 56 ligament laxity 56 colorectal adenocarcinoma 56 proximal humerus 56 thymic carcinoma 56 Tavocept 56 synovial sarcoma rare 56 thetreatment 56 multicentric 56 platinum refractory 56 cranio 56 Genasense R 56 Artelon ® 56 colorectal liver metastases 56 oral ridaforolimus 56 Squamous Cell Carcinoma 56 partial meniscectomy 55 osteoid osteoma 55 hypertrophic scars 55 pancreatic carcinoma 55 Ganite ® 55 histologic examination 55 diaphysis 55 intravenous belinostat 55 debrided 55 metastatic HRPC 55 KYPHON Balloon Kyphoplasty 55 INSPIRE Trial Phase III 55 Kit CD# positive 55 mCRPC 55 oral picoplatin 55 indolent NHL 55 metaplasia 55 liver resection 55 rALLy clinical trial 55 Phase 1b clinical trials 55 Hepatocellular Carcinoma HCC 55 paraspinal muscles 55 Soft Tissue Sarcoma 55 peritoneal carcinomatosis 55 BR.# 55 AZX# 55 gastroduodenal 55 huC# DM4 55 locoregional recurrence 55 successfully commercialize Iluvien 55 tibial plateau fractures 55 anti angiogenic agents 55 soft tissue 55 postoperative radiographs 55 budesonide foam 55 soft tissue sarcomas 55 vascularized 55 histologic subtype 55 nodal metastasis 55 intravenous bisphosphonate therapy 55 benign biliary strictures 55 axilla 55 PresbyLens ® 55 PROCHYMAL 55 ligament tendon 55 completely resected 55 Targretin capsules 55 lintuzumab SGN 55 thoracic aortic aneurysms 55 tunica vaginalis 55 Phase IIIb clinical 55 intracavitary 55 lung cancer NSCLC 55 lumbar spine fusion 55 estramustine 55 oral maxillofacial 55 delivers fluocinolone acetonide FA 55 Afatinib 55 histologically proven 55 cholangiocarcinoma 55 infraspinatus 55 revascularized 55 histologies 55 distal clavicle 55 total thyroidectomy 55 VATS lobectomy 55 avulsions 55 recurrent glioma 55 osteoinductive 55 proximal radius 55 malignant ovarian 55 underwent resection 55 hypertrophic scarring 55 HER2 positive metastatic breast 55 Bayer HealthCare Onyx Pharmaceuticals 55 Phase #b/#a clinical 55 AlphaCor 55 Pivotal Phase III 55 medial cuneiform 55 Chronic lymphocytic leukemia 55 cartilage defects 55 diabetic ulcer 55 taxane resistant 55 retroperitoneal 54 ganetespib 54 Pivotal Trial 54 Synovial sarcoma 54 nonmetastatic 54 tuberosity 54 Dupuytren Contracture 54 discogenic pain 54 thoracolumbar spine 54 biliary tract cancer 54 keratoplasty 54 Darinaparsin 54 ThermoDox R 54 osteochondral defects 54 Fibrillex TM 54 hematological indications 54 Radiofrequency ablation 54 GTC recombinant form 54 evaluating T DM1 54 undergoing spinal fusion 54 actinic keratoses AKs 54 tibial tubercle 54 multicenter clinical trials 54 phase IIb clinical 54 postoperative pathology 54 MAGE A3 ASCI 54 systemic anaplastic large 54 intertrochanteric 54 AzaSite Plus 54 vascular lesion 54 stage IIIb IV 54 Virulizin ® 54 osteochondromas 54 lateral femoral condyle 54 pectoralis major 54 situ CIS 54 removed laparoscopically 54 trabecular bone 54 osteoarthritic 54 osseointegration 54 Budesonide foam crofelemer 54 ganglion cysts 54 embolizations 54 Proellex TM 54 ELACYT 54 refractory metastatic 54 AA amyloidosis 54 Combination REOLYSIN R 54 acromioclavicular 54 BioCart ™ System 54 ulcers diabetic ulcers 54 receptor tyrosine kinase inhibitor 54 IL# PE#QQR 54 Tarceva TM 54 including eniluracil ADH 54 subtalar 54 fallopian tube cancers 54 cutaneous squamous cell carcinoma 54 squamous 54 Circulating tumor cells 54 nerve decompression 54 Orphan Drug Status 54 labral tears 54 PrevOnco ™ 54 octreotide implant 54 talar dome 54 genitourinary tract 54 cervical fusion 54 achieved CCyR 54 adjuvant radiation 54 gastric pancreatic 54 neoadjuvant therapy 54 resections 54 thoracolumbar 54 swollen lymph node 54 distal radius 54 intracranial aneurysms 54 Accelerated Partial Breast Irradiation 54 interstitial brachytherapy 54 Européenne Mark 54 radiofrequency ablation RFA 54 femoral fracture 54 distal radius fractures 54 humeral fractures 54 LEUKINE 54 TACI Ig 54 blood clot dissolving 54 infiltrative 54 interbody fusion 54 arteriotomy 54 nodular melanoma 54 clinicopathological features 54 radioiodine therapy 54 thrombi 54 intravesical infusion therapy 54 BRIM2 54 samalizumab 54 Computed tomography 54 forodesine 54 OvaRex R 54 pathological fractures 54 talar 54 arteriovenous malformations 54 GRN# 54 plain radiographs 54 cutaneous T 54 Transcatheter 54 heterotopic bone 53 osteoconductive 53 treat facial wrinkles 53 tenotomy 53 arthrodesis 53 ERBITUX Cetuximab 53 histologically confirmed 53 chemoradiation therapy 53 rALLy 53 periodontal defects 53 Visian Toric ICL 53 haematologic 53 proximal tibia 53 non metastatic resectable 53 neovascular diseases 53 uterus fallopian tubes 53 radical nephrectomy 53 mTOR inhibitors 53 steroid refractory GvHD 53 axillary lymph nodes 53 visceral metastases 53 hereditary deficiency 53 recurrent metastatic ovarian cancer 53 advanced pancreatic neuroendocrine 53 Embozene TM Microspheres 53 lumbosacral spine 53 incisional 53 urothelial carcinoma 53 Bezielle 53 Allovectin 7 R 53 Tyrosine Kinase Inhibitors 53 phakic 53 surgical decompression 53 metastatic malignant melanoma 53 bilateral orchiectomy 53 UPLYSO 53 radiation sensitizer 53 Fibrin Pad 53 iliac 53 Ganite R 53 meniscal tears 53 intramedullary nails 53 cisplatin chemotherapy 53 telangiectasias 53 MCSP respectively 53 Nimotuzumab 53 corneal wound 53 brivanib 53 trastuzumab Herceptin R 53 revision arthroplasty 53 gemcitabine carboplatin 53 contractile muscle 53 unique alkylating agent 53 ospemifene 53 submucosal 53 prostate cancer HRPC 53 thoracic aortic 53 vismodegib 53 intrathoracic 53 vertebral compression fractures VCFs 53 refractory colorectal cancer 53 prospectively stratified 53 galiximab 53 bladder augmentation 53 meniscal repair 53 radicular 53 Initiates Enrollment 53 periorbital 53 hyaluronidase enzyme 53 adnexal 53 penetrating keratoplasty 53 Entereg R 53 Personalized Immunotherapy 53 operable breast cancer 53 Avascular necrosis 53 proximal tibial 53 venous reflux 53 Nicole Onetto MD 53 Cloretazine R VNP#M 53 treating vertebral compression 53 rheumatoid arthritis psoriatic arthritis 53 disc arthroplasty 53 conformal radiotherapy 53 AML acute myeloid 53 transesophageal echocardiography 53 COMFORT II 53 venous stasis 53 locoregional disease 53 extra articular 53 xenograft 53 urothelial 53 dasatinib Sprycel ® 53 distal tibia 53 ductal carcinomas 53 HoFH 53 elacytarabine 53 transabdominal 53 neoadjuvant treatment 53 limb lengthening 53 renal pelvis 53 ADVEXIN p# therapy 53 posterior fossa 53 reinnervation 53 proximal humeral fractures 53 ablation procedures 53 Additionally Nexavar 53 Sirtex SIR Spheres microspheres 53 impingement syndrome 53 resectable 53 anastomotic devices 53 adjuvant colon cancer 53 medial compartment 53 synovial 53 Bone grafts 53 extracapsular extension 53 K ras mutations 53 arthroscopic debridement 53 labral repair 53 Cimzia TM 53 IV metastatic melanoma 53 CLL SLL 53 GTC recombinant human 53 bile duct tumor 53 lymph node involvement 53 Urocidin 53 visit www.dobimedical.com 53 ZYBRESTAT fosbretabulin 53 lesional 53 hydroxyapatite coated 53 cortical bone 53 Phase #/#a trial 53 Adenomas 53 evaluating tivozanib 53 Phakic 53 Histological 52 LymphoStat B belimumab 52 cervical thoracic 52 lumbar disc herniation 52 Radiographs 52 femoral fractures 52 osteochondroma 52 avascular 52 MMP inhibitors 52 tendinosis 52 intraductal 52 toenail onychomycosis 52 R lenalidomide 52 femoral neck fracture 52 degenerative spondylolisthesis 52 Arteriovenous 52 Albuferon TM 52 vascular anatomy 52 oral prodrug 52 hypoplasia 52 echogenicity 52 proximal femur 52 intramedullary nailing 52 bladder rectum 52 arthrosis 52 descending thoracic aorta 52 resection arthroplasty 52 riociguat 52 sorafenib tablets 52 RANK Ligand inhibitor 52 cartilage defect 52 castrate resistant 52 endoluminal 52 photoaged skin 52 Crofelemer budesonide foam 52 CIMZIA ™ 52 intervertebral disc 52 nonsurgical treatment 52 lumbar spinal 52 proximal femoral 52 breast carcinoma 52 haematological malignancies 52 Amrubicin 52 pulmonary artery banding 52 Anturol TM 52 severe hypersensitivity reactions 52 Intra articular 52 class mGluR5 inhibitor 52 hoFH 52 metastatic sarcomas 52 histological subtype 52 functional mitral regurgitation 52 lumbar disk herniation 52 breast carcinomas 52 Glioblastoma Multiforme 52 CA4P 52 Tectin TM 52 Hedgehog Pathway Inhibitor 52 SpideRX 52 cutaneous melanoma 52 deformity correction 52 metastatic RCC 52 radiographically 52 axitinib 52 evaluating REVLIMID 52 circulating endothelial cells 52 BCG refractory 52 vidofludimus 52 treatment naive genotype 52 CardioPass TM 52 iliac crest 52 T1c 52 MGN# 52 EDEMA3 trial 52 Ceplene/IL-2 52 posterolateral fusion 52 liver metastasis 52 PI3K/Akt pathway inhibitor 52 bioresorbable 52 urethral stricture 52 Evoltra ® 52 BrachySil TM 52 olecranon 52 meniscectomy 52 epiretinal 52 refractory chronic lymphocytic 52 immune modulating 52 Clolar ® 52 maxilla 52 Zybrestat 52 SUPPRELIN R LA 52 Cellegesic 52 DIFICID ™ 52 calcific 52 budesonide MMX Phase III 52 Methylnaltrexone 52 Vitrasert R 52 Mitroflow 52 cMET 52 coracoid 52 refractory Hodgkin 52 Phase 2b Clinical Trial 52 ruxolitinib 52 subcutaneous tissues 52 ProDisc L 52 BioNumerik 52 TheraCIM 52 liver resection surgeries 52 tibial shaft 52 patellofemoral 52 abdominal aortic 52 Metastatic Colorectal Cancer 52 GED aPC 52 Hodgkin lymphoma HL 52 bardoxolone methyl 52 pancreatic transplantation 52 unicompartmental 52 femoroacetabular impingement 52 seroma formation 52 sacrocolpopexy 52 ZACTIMA 52 gastrointestinal malignancies 52 lymphadenectomy 52 periosteal 52 transmural 52 bone metastasis 52 Medtronic CoreValve System 52 Group RTOG 52 Panzem R NCD 52 #,# Visian ICLs 52 medial malleolus 52 vapreotide acetate 52 implanted subcutaneously 52 Prestara 52 epiphysis 52 intraocular lens implantation 52 distal femoral 52 Tibial 52 ischemic mitral regurgitation 52 Carfilzomib 52 splenic 52 basilar 52 Perifosine 52 BRAF V# mutation 52 trophoblasts 52 iUni 52 lomitapide 52 IgG1 monoclonal antibody 52 cSSSI 52 antiresorptive 52 PrevOnco 52 aortic dissections 52 chemoembolization 52 HRPC 52 lymphoma CTCL 52 unresectable stage 52 epithelial ovarian 52 BEXXAR Therapeutic Regimen 52 Severe hypersensitivity reactions 52 sarcomatoid 52 Efficacy endpoints included 51 KIACTA ™ 51 L5 S1 51 lumbar interbody fusion 51 subchondral 51 PFO closure 51 briakinumab 51 PRIMO CABG 51 trochanteric 51 engineered urethras 51 de novo AML 51 meningeal 51 thoracic aortic aneurysm 51 Fast Track designations 51 intralesional 51 rALLy trial 51 nonunion fractures 51 OvaRex ® MAb 51 treat menorrhagia 51 infarcted myocardium 51 KRAS mutated 51 InterStim Therapy 51 embolisation 51 EchoCRT 51 Phase IIb clinical trials 51 CR# vcMMAE 51 investigational therapies 51 ipsilateral breast 51 nonoperative treatment 51 callus formation 51 hallux rigidus 51 metacarpophalangeal joint 51 Cloretazine ® 51 EGFr expressing metastatic colorectal 51 PATHFINDER R 51 relapsed refractory multiple myeloma 51 subchondral bone 51 Investigational Device Exemption IDE 51 spinal vertebrae 51 regenerate cartilage 51 cytotoxic therapies 51 bioprosthetic 51 periarticular 51 ongoing Phase 1b 51 TORISEL 51 heavily pretreated patients 51 phakic intraocular lens 51 biomechanical integrity 51 biliary tree 51 precancerous lesion 51 nonischemic 51 REPEL CV 51 viral reactivation 51 deforolimus 51 PRECISE Trial 51 pediatric glioma 51 breast brachytherapy 51 lumbar discectomy 51 Stabilimax NZ 51 MEK Inhibitor 51 AGILECT R 51 tubulin inhibitor 51 scaphoid fractures 51 taxane refractory 51 glenohumeral 51 dental reconstructive 51 Virulizin R 51 collateral ligaments 51 Granted Orphan Drug 51 tramiprosate Alzhemed TM 51 lateral malleolus 51 lung carcinomas 51 keloid 51 TAXUS Stents 51 cutaneous T cell 51 unblock clogged arteries 51 glenohumeral joint 51 Application MAA 51 MR arthrography 51 HGS ETR2 51 decompressive surgery 51 metastatic renal cell carcinoma 51 Skin grafts 51 trabecular 51 mucinous 51 computed tomographic 51 Phase III pivotal 51 nerve entrapment 51 lunate 51 oncologic diseases 51 paragangliomas 51 registrational Phase 51 Bioabsorbable 51 prostatic bed 51 imexon 51 dirucotide MBP# 51 osteotomies 51 OMAPRO ™ 51 schwannoma 51 complicated intra abdominal 51 MGuard ™ 51 lumbosacral 51 vernakalant hydrochloride 51 Ectopia Cordis 51 medullary thyroid cancer 51 Phase III Pivotal 51 LymphoStat B TM 51 ureteral stents 51 StemEx 51 BRCA deficient 51 randomized Phase IIb 51 venous ulcers 51 Behcet uveitis 51 Prospective Randomized 51 XIENCE V Stent System 51 PEG SN# 51 interpositional 51 Oral Calcitonin 51 haematomas 51 follicular Non Hodgkin 51 MelaFind R 51 stage IIIB 51 Renal Cell Carcinoma RCC 51 cediranib 51 fuse vertebrae 51 intravenous bisphosphonates 51 arthroplasties 51 vascular malformations 51 Tanespimycin 51 curative resection 51 fibrous dysplasia 51 tibial nerve 51 subretinal 51 Dacogen injection 51 Levacor TM 51 multicenter Phase II 51 DXA scan 51 disc herniations 51 Ganetespib 51 ankle arthrodesis 51 Temporomandibular Joint 51 advanced metastatic prostate 51 Cutaneous T 51 Orphan Drug status 51 arthroscopies 51 hyaline cartilage 51 gastrointestinal mucositis 51 underwent radical cystectomy 51 vemurafenib 51 enzastaurin 51 metastatic hormone refractory 51 luxation 51 nonoperative 51 ovarian carcinoma 51 MIVI TRUST 51 bones muscles tendons 51 BRIM3 51 implantations 51 Trial Evaluating 51 treat chronic sinusitis 51 Meets Primary Endpoint 51 valve implantation 51 epithelial layer 51 Eon Mini neurostimulator 51 TKAs 51 joints tendons 51 inguinal hernia repair 51 NP2 Enkephalin 51 olaparib 51 microcatheters 51 tumor metastases 51 heterotopic ossification 51 bavituximab monotherapy trial 51 telangiectasia 51 pleomorphic 51 Advanced Renal Cell 51 spinal compression fractures 51 Ceflatonin 51 lumbar fusion 51 Evoltra TM 51 NSABP C 51 avulsion fractures 51 lymphocytosis 51 percutaneously 51 coagulation disorders 51 intravenous iclaprim 51 Laser Lok 51 SinuNase TM 51 intramedullary nail 51 osteoporotic bone 51 triphendiol 51 vinflunine 51 Synchrony lens 51 mesenchymal stem cell 51 Colon polyps 51 follicular thyroid cancer 51 submandibular gland 51 eosinophilic asthma 51 novel emulsion formulation 51 metastatic castration resistant 51 canal stenosis 51 Phase Ib IIa 51 longus 51 eSVS MESH 51 p# inhibitor 51 disc bulges 51 hydronephrosis 50 carotid artery stenting 50 dissolvable sutures 50 PANVAC VF 50 Xcytrin R 50 metastatic androgen independent 50 posterolateral 50 Urocidin TM 50 LibiGel Phase III 50 bullae 50 Daclizumab 50 nasal calcitonin product 50 CA9 SCAN 50 diarrhea predominant irritable 50 resected 50 refractory metastatic colorectal cancer 50 small keyhole incisions 50 sorafenib Nexavar ® 50 post operative ileus 50 surgical resection cavity 50 diagnosed glioblastoma 50 trastuzumab DM1 T DM1 50 sacral nerve stimulation 50 evaluating picoplatin 50 total knee arthroplasties 50 ThermoDox ® clinical 50 Receives Orphan Drug 50 regenerating cartilage 50 adjuvant radiotherapy 50 Triapine 50 omega interferon 50 distraction osteogenesis 50 BioSTAR ® 50 Resolute DES 50 urologic gynecologic 50 anti EGFR antibody 50 acute HAE attacks 50 equivocal appendicitis 50 coronary artery bypass grafts 50 locoregional 50 candidates Augment ™ 50 reconstructive procedures 50 spine fusion 50 Artificial Disc 50 pelvic ultrasound 50 Langerhans cell histiocytosis 50 Acute Radiation Syndrome ARS 50 adjuvant GIST 50 tibial sesamoid 50 infrarenal 50 alvespimycin 50 cervical spinal cord 50 orthopedics neurosurgery 50 expanded polytetrafluoroethylene 50 IMC #B 50 trochanteric bursitis 50 inguinal hernias 50 dacarbazine DTIC 50 AneuRx 50 cartilage tendons 50 Septic arthritis 50 ligamentous laxity 50 thoracoabdominal 50 renal carcinoma 50 methylnaltrexone bromide 50 relapsed AML 50 submandibular 50 grade serous ovarian 50 common bile duct 50 Doxil ® 50 Generx TM 50 TOCOSOL Camptothecin 50 intramedullary 50 metastatic renal cell 50 MVax 50 keratoprosthesis 50 Hematologic 50 alvimopan 50 YONDELIS R 50 osteochondral 50 PFO migraine 50 MediGene focuses 50 Azedra 50 GLPG# 50 HeartMate XVE 50 Immunotherapeutic 50 hyperkeratotic 50 nodal metastases 50 granted Ortec 50 Completes Patient Enrollment 50 TNF blocker therapy 50 nonmetastatic prostate cancer 50 Panzem R 50 vein ablation 50 Arthroscopic 50 Amigal TM 50 prior nephrectomy 50 refractory Hodgkin lymphoma 50 mutational status 50 skeletally immature patients 50 osteochondral lesions 50 metastatic relapsed 50 solid tumors 50 umbilical hernias 50 Prodarsan R 50 placebo controlled clinical 50 surgical debridement 50 mg/m2 cohort 50 neratinib 50 cancellous 50 laminectomies 50 Bioral Amphotericin B 50 scar tissue encapsulating pacing 50 Spinal Cord Stimulation 50 cetuximab Erbitux 50 Brentuximab Vedotin SGN 50 SNT MC# 50 malignant tumors 50 spinal fusion procedures 50 Fast Track Status 50 node dissection 50 Pseudomonas aeruginosa infections 50 periocular 50 Alequel 50 cervical disc 50 interspinous 50 capsulitis 50 peroneal 50 sacral spine 50 prognostic variables 50 Diabetic Macular Edema 50 regenerative therapy 50 bladder carcinoma 50 Pixantrone 50 treat uterine fibroids 50 femoral condyle 50 Luveniq 50 popliteal 50 urocortin 2 50 Medtronic Infuse 50 Orphan Status 50 neoadjuvant 50 evaluating mipomersen 50 androgen suppression 50 Campath ® 50 dural repair 50 rBChE 50 RVOT 50 cytoreductive nephrectomy 50 choroidal melanoma 50 Taxus Element 50 articular cartilage defects 50 fibromatosis 50 varus deformity 50 AVOREN 50 Oracea TM 50 Neuradiab 50 AQ4N 50 endoprosthesis 50 induced macular edema 50 bioabsorbable 50 engineered bladders 50 explanted 50 HCV SPRINT 50 intertrochanteric fractures 50 forodesine hydrochloride BCX 50 synthetic retinoid 50 TM pralatrexate injection 50 patellar ligament 50 retinal detachments 50 ponatinib 50 pT2 50 IEQ kg 50 Raptiva ® 50 Severe VOD 50 molecular biomarkers 50 adecatumumab 50 epiphyseal 50 catheter occlusion CO 50 glenoid bone 50 systemic immunosuppressive drugs 50 TAXUS stents 50 osteophytes 50 meniscal tear 50 CONBRIZA 50 ACTEMRA TM 50 aneurysmal bone cyst 50 neuropathies 50 CardioPass